Epidemiology and treatment of beta thalassemia major in China

Abstract Thalassemia, classified as the main types α‐ and β‐thalassemia, is a single gene disorder resulting from globin chain synthesis impairment through the mutation or deletion of globin genes. The incidence of thalassemia is high worldwide, with high associated mortality. Therefore, treatment i...

Full description

Bibliographic Details
Main Authors: Xiaoxiao Xu, Xuedong Wu
Format: Article
Language:English
Published: Wiley 2020-03-01
Series:Pediatric Investigation
Subjects:
Online Access:https://doi.org/10.1002/ped4.12154
_version_ 1818948132282564608
author Xiaoxiao Xu
Xuedong Wu
author_facet Xiaoxiao Xu
Xuedong Wu
author_sort Xiaoxiao Xu
collection DOAJ
description Abstract Thalassemia, classified as the main types α‐ and β‐thalassemia, is a single gene disorder resulting from globin chain synthesis impairment through the mutation or deletion of globin genes. The incidence of thalassemia is high worldwide, with high associated mortality. Therefore, treatment is important to improve patient outcomes. This paper reviews the current status of β‐thalassemia major in China, including its epidemiology and treatment.
first_indexed 2024-12-20T08:41:56Z
format Article
id doaj.art-0c14f5e980ce43a28089375b042af747
institution Directory Open Access Journal
issn 2574-2272
language English
last_indexed 2024-12-20T08:41:56Z
publishDate 2020-03-01
publisher Wiley
record_format Article
series Pediatric Investigation
spelling doaj.art-0c14f5e980ce43a28089375b042af7472022-12-21T19:46:22ZengWileyPediatric Investigation2574-22722020-03-0141434710.1002/ped4.12154Epidemiology and treatment of beta thalassemia major in ChinaXiaoxiao Xu0Xuedong Wu1Departments of pediatrics Nanfang Hospital Southern Medical University Guangzhou Guangdong ChinaDepartments of pediatrics Nanfang Hospital Southern Medical University Guangzhou Guangdong ChinaAbstract Thalassemia, classified as the main types α‐ and β‐thalassemia, is a single gene disorder resulting from globin chain synthesis impairment through the mutation or deletion of globin genes. The incidence of thalassemia is high worldwide, with high associated mortality. Therefore, treatment is important to improve patient outcomes. This paper reviews the current status of β‐thalassemia major in China, including its epidemiology and treatment.https://doi.org/10.1002/ped4.12154ThalassemiaEpidemiologyTreatmentChina
spellingShingle Xiaoxiao Xu
Xuedong Wu
Epidemiology and treatment of beta thalassemia major in China
Pediatric Investigation
Thalassemia
Epidemiology
Treatment
China
title Epidemiology and treatment of beta thalassemia major in China
title_full Epidemiology and treatment of beta thalassemia major in China
title_fullStr Epidemiology and treatment of beta thalassemia major in China
title_full_unstemmed Epidemiology and treatment of beta thalassemia major in China
title_short Epidemiology and treatment of beta thalassemia major in China
title_sort epidemiology and treatment of beta thalassemia major in china
topic Thalassemia
Epidemiology
Treatment
China
url https://doi.org/10.1002/ped4.12154
work_keys_str_mv AT xiaoxiaoxu epidemiologyandtreatmentofbetathalassemiamajorinchina
AT xuedongwu epidemiologyandtreatmentofbetathalassemiamajorinchina